市场调查报告书
商品编码
1249920
全球睡眠呼吸暂停设备市场 - 按产品、最终用途、2023-2032 年预测Sleep Apnea Devices Market - By Product, By End-use & Global Forecast, 2023 - 2032 |
由于睡眠障碍和相关合併症的增加,预计到 2032 年睡眠呼吸暂停设备将保持积极的发展轨迹。
据可靠报导,大约有 2200 万美国人患有睡眠呼吸暂停症。 睡眠呼吸暂停在老年人口和相关健康状况中的患病率不断增加,这增加了对睡眠障碍诊断和治疗设备的需求。
治疗阻塞性睡眠呼吸暂停的最新方法是 Inspire 系统。 通过激活舌头和呼吸道的肌肉,它不仅试图治疗症状,而且试图从根本上治疗睡眠呼吸暂停综合征。 这些围绕睡眠呼吸暂停的发展有望在未来几年为市场扩张提供有利可图的机会。
总体而言,睡眠呼吸暂停设备行业根据产品、最终用途和区域进行细分。
基于产品,诊断行业预计将在未来几年继续快速增长。 在睡眠呼吸暂停治疗设备领域,不断的技术创新正在扩大其在全球范围内的使用范围。 这些设备具有非侵入式监测睡眠週期和提供随时间变化的睡眠模式图形摘要的多重优势。
就最终用途而言,到 2032 年底,睡眠实验室和医院部分将保持强劲势头,因为患者越来越喜欢睡眠实验室和医院,因为他们的高质量睡眠障碍治疗和可负担性预计会增长。 此外,睡眠实验室和医院能够做出准确的诊断并提供准确有效的治疗,从而以可承受的价格提供最佳的治疗效果。
按地区划分,预计从 2023 年到 2032 年,亚太地区的睡眠呼吸暂停治疗行业将出现显着增长。 由于睡眠呼吸暂停综合征患病率上升,预计该地区的市场增长将主要受到对睡眠呼吸暂停综合征早期诊断需求不断增长的推动。 一项关于阻塞性睡眠呼吸暂停低通气综合征的研究发现,OSA 在印度次大陆的患病率在 4.4% 到 13.7% 之间。
越来越多的市场进入者、积极的政府举措和发达的医疗保健基础设施也将对该地区的前景产生积极影响。 预计亚太地区老龄化人口的快速增加将推动业务增长,并在未来几年进一步加速市场扩张。
Sleep Apnea Devices industry will depict positive trajectory through 2032 owing to the increasing prevalence of sleep disorders and related co-morbidities. According to credible reports, around 22 million Americans have sleep apnea. The growing senior population prone to sleep apnea and related health conditions have bolstered the demand for sleep disorders diagnosis & treatment equipment.
The most recent method of treating obstructive sleep apnea is the Inspire system. Inspire attempts to treat the root of sleep apnea, not just the symptoms, by activating the tongue and airway muscles. Such developmental trends around sleep apnea are likely to offer lucrative opportunities to the market expansion in the coming years.
Overall, the sleep apnea devices industry is segmented in terms of product, end-use and region.
Based on the product, the diagnostics segment will grow rapidly through 2032 due to the increasing demand for sleep apnea devices for sleep disease diagnosis and rising awareness regarding the benefits of advanced diagnostic sleep apnea devices. Constant technological innovations in the field of sleep apnea devices is enhancing its use globally. These devices offer multiple advantages in monitoring sleep cycles using a non-invasive method and providing a graphical summary of sleep patterns over time.
By end-use, the sleep laboratories & hospitals segment will demonstrate sturdy growth by 2032 end, owing to the increasing preference of patients towards sleep laboratories & hospitals for quality sleep disorders treatment and affordability. In addition, sleep laboratories & hospitals offer an accurate diagnosis that empower precise & effective treatment, thus delivering optimal treatment outcomes along with affordability.
Regionally, the Asia Pacific sleep apnea devices industry is estimated to garner notable gains during 2023-2032. The regional market growth will come from the mounting demand for early diagnosis of sleep apnea, mainly due to the rising prevalence of sleep apnea. As per a study on Obstructive Sleep Apnea Hypopnea Syndrome, the OSA prevalence ranges from 4.4% to 13.7% in the Indian subcontinent.
Besides, the increasing number of key participants entering the market, along with favorable government initiatives and well-developed healthcare infrastructure, will favor the regional outlook. The surging geriatric population base in the Asia Pacific region is anticipated to push the business growth, further amplifying the market expansion in the coming years.